Optimizing the Dosing Regimens of Tigecycline against Vancomycin-Resistant Enterococci in the Treatment of Intra-abdominal and Skin and Soft Tissue Infections

Tigecycline was previously considered to have activity against vancomycin-resistant Enterococcus (VRE) isolates, but the optimal dose was not clarified. Thus, this study assessed the in vitro activity of tigecycline against clinical VRE isolates to determine its optimal regimens for complicated intr...

Descripción completa

Detalles Bibliográficos
Autores principales: Santimaleeworagun, Wichai, Hemapanpairoa, Jatapat, Changpradub, Dhitiwat, Thunyaharn, Sudaluck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533206/
https://www.ncbi.nlm.nih.gov/pubmed/32989939
http://dx.doi.org/10.3947/ic.2020.52.3.345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533206/
https://www.ncbi.nlm.nih.gov/pubmed/32989939
http://dx.doi.org/10.3947/ic.2020.52.3.345

Ejemplares similares